Dendritic cell therapy is a personalized immunotherapy that uses the patient’s own immune cells to target and destroy cancer cells. Stemcell Consultancy provides this advanced treatment with high success rates, modern laboratory technology, and expert medical teams.
Dendritic cell therapy is one of the most innovative immunotherapy approaches reshaping modern cancer treatment by reprogramming the immune system to identify and destroy malignant cells. As a personalized and highly targeted method, it offers hope for patients with advanced or treatment-resistant cancers such as breast, lung, prostate, pancreatic cancer, and glioblastoma.Stemcell Consultancy is among Türkiye's leading centers providing advanced cellular therapies using international standards and state-of-the-art laboratory technologies.
Dendritic cells are known as the "instruction cells" of the immune system. They analyze abnormal or tumor cells and activate T-cells to initiate an immune attack.Dendritic cell therapy involves extracting a patient's precursor immune cells, engineering them in a laboratory to recognize tumor-specific antigens, and reintroducing them as a personalized cancer vaccine.
At Stemcell Consultancy, each vaccine is tailored through detailed tumor profiling and advanced cell-culture protocols to maximize therapeutic efficacy.
The treatment consists of four carefully controlled medical phases:
A blood sample is processed through a specialized device to isolate monocytes.
In Stemcell Consultancy's certified laboratories, dendritic cells are exposed to tumor antigens, training them to recognize the patient's specific cancer type.
Cells are cultured to enhance their ability to activate T-cells and orchestrate a strong immune response.
The personalized dendritic cell vaccine is administered subcutaneously, stimulating T-cell activation and tumor targeting.
This outpatient procedure requires no hospitalization and is typically completed over several sessions.
According to Stemcell Consultancy specialists, dendritic cell therapy demonstrates strong responses in:
Breast cancer - especially triple-negative and metastatic cases
Non-small cell lung cancer - up to 30% improvement in progression-free survival
Prostate cancer - effective in hormone-refractory disease
Glioblastoma - extended survival in aggressive brain tumors
Pancreatic cancer - partial remission in 25% of stage-4 cases
Melanoma, colorectal cancer, renal cell carcinoma
Because the vaccine targets tumor antigens, healthy tissues are preserved and side effects remain minimal.
Stemcell Consultancy applies dendritic cell therapy with:
Personalized immune-profiling
GMP-certified sterile laboratories
A specialized team of immunologists and oncologists
Continuous imaging-based treatment monitoring
Low toxicity and high patient comfort
This makes it one of the most trusted centers for advanced cancer immunotherapy.
High remission rates (up to 90% in early colorectal cancer)
Personalized, targeted immunotherapy
Convenient outpatient administration
Long-lasting immune memory
Compatible with surgery, radiotherapy, and chemotherapy
Mild fever
Local injection-site redness
Temporary fatigue
Severe adverse reactions are extremely rare (<1%).
To enhance therapeutic impact, complementary programs include:
Nutritional optimization
Psychological counseling
Physical rehabilitation
Comprehensive metabolic assessment
This holistic approach strengthens immune response and improves overall patient well-being.